Table 1.
Characteristics of Subjects
| Sites | |||
|---|---|---|---|
| Nashville | U.S.* | Europe** | |
|
| |||
| MULTIPLE SCLEROSIS (total) | 84 | 81 | 80 |
|
| |||
| CIS | 14 | 10 | |
| Treatment naïve | 30 | 4 | 55 |
| Established disease (on meds) | 40 | 77 | 15 |
|
| |||
| OND-I (total) | 1 | 85 | |
|
| |||
| Acute disseminated encephalomyelitis | 4 | ||
| Bell’s Palsy | 3 | ||
| CNS lupus | 2 | ||
| Guillaine Barre | 4 | ||
| Myasthenia Gravis | 3 | ||
| Neuromyelitis optica | 27 | ||
| Optic neuritis | 1 | 1 | |
| Transverse myelitis | 41 | ||
|
| |||
| OND-NI (total) | 1 | 128 | |
|
| |||
| Alzheimer’s | 6 | ||
| Cerebral ataxia | 2 | ||
| Cerebral bleed | 2 | ||
| Cervical radiculopathy | 6 | ||
| Drug-induced movement disorder | 1 | ||
| Dystonia | 1 | ||
| Epilepsy | 1 | 4 | |
| Essential tremor | 9 | ||
| Huntington’s disease | 1 | ||
| Hydrocephalus | 1 | ||
| Median Neuropathy | 2 | ||
| Meningioma | 1 | ||
| Migraine | 30 | ||
| Parkinson’s | 3 | 0 | |
| Peripheral Neuropathy | 1 | ||
| Pseudotumor | 3 | ||
| Restless Leg Syndrome | 1 | ||
| Seizures | 6 | ||
| Spasmodic torticollis | 1 | ||
| Stroke | 18 | ||
| Tourette’s Syndrome | 1 | ||
| Transient Ischemia | 1 | ||
|
| |||
| CONTROLS | 48 | 61 | |
*
six additional sites in U.S.: MA, MD, NY, SC, AZ, TX, CA, samples from sites in MS, MD, NY, AZ, and CA were obtained through the Accelerated Cure Project.
**
Denmark, Netherlands